drugset / Trial / NCT06324604
Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients
RandomizedCrossoverTriple-blindBasic science
Summary
First in human study to understand the potential side effects of MTX-101, how long MTX-101 lasts in the human body, and how MTX-101 affects specific human immune cells.
Timeline
- Start
- 2024-06-13
- Primary completion
- 2027-03-31
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MTX101 | Unknown | — | Intravenous |